Hepatic, metabolic, and nutritional disorders of alcoholism: From pathogenesis to therapy

Critical Reviews in Clinical Laboratory Sciences

Volumn 37, Issue 6, 2000, Pages 551-584

  Lieber, C S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alcoholic liver disease; CYP2E1; Diagnosis; Dilinoleoylphosphatidylcholine (DLPC); Polyenylphosphatidylcholine (PPC); S adenosylmethionine (SAMe); Therapy

Indexed keywords

ACAMPROSATE; ALCOHOL; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; COLCHICINE; CYTOCHROME P450 2E1; CYTOCHROME P450 INHIBITOR; CYTOKINE; ENDOTOXIN; ESSENTIAL AMINO ACID; FREE RADICAL; INTERFERON; LIVER ENZYME; METHIONINE; NALTREXONE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE METHYLTRANSFERASE; S ADENOSYLMETHIONINE; STEROID;

ALCOHOL LIVER DISEASE; ALCOHOLISM; AMINO ACID METABOLISM; DRUG CONTRAINDICATION; ENZYME INACTIVATION; HEPATITIS C; IMMUNOREGULATION; LIVER TRANSPLANTATION; METABOLIC DISORDER; NUTRITIONAL DISORDER; NUTRITIONAL REQUIREMENT; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; PATHOGENESIS; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; REVIEW; WITHDRAWAL SYNDROME;

EID: 0034530876     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408360091174312     Document Type: Review

References (248)

1. Prognostic factors in alcoholic liver disease
2. Fatty liver: A study of 270 patients with biopsy proven fatty liver and a review of the literature
3. Pathogenesis and natural course of alcoholic liver disease
4. Effects of prolonged ethanol intake: Production of fatty liver despite adequate diets
5. Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets
6. Perivenular fibrosis as precursor lesion of cirrhosis
7. Hepatic fibrosis in alcoholics: Morphologic characteristics, clinical diagnosis, and natural course
8. Sequential production of fatty liver, hepatitis and cirrhosis in sub-human primates fed ethanol with adequate diets
9. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin
10. Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine
11. Portal fibroblasts and myofibroblasts in baboons after long-term alcohol consumption
12. Lipocytes and transitional cells in alcoholic liver disease: A morphometric study
13. Alcoholic liver injury in baboons: Transformation of lipocytes to transitional cells
14. The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies
15. Acetaldehyde selectively stimulates collagen production in cultured rat liver-storing cells but not in hepatocytes
16. Liver biopsy and liver function tests in 28 consecutive long-term alcoholics
17. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse
18. Prospective evaluation of alcohol abuse and alcoholic liver injury in man as predictors of development of cirrhosis
19. Chronic alcoholism with fatty metamorphosis of the liver
20. The early stage of liver injury in the alcoholic
21. Ultrastructural studies in alcoholic liver disease
22. The evolution of human cirrhosis deduced from observations in experimental animals
23. Occlusive venous lesions in alcoholic liver disease. A study of 200 cases
24. Early perivenular sclerosis in alcoholic fatty liver: An index of progressive liver injury
25. Alterations in endothelial fenestrations in liver sinusoids of baboons fed alcohol: A scanning electron microscopic study
26. Relation of portal cirrhosis to hemochromatosis and to diabetes mellitus
27. The role of alcoholism in hepatic iron storage disease
28. Alcohol related diseases and carcinogenesis
29. Naltrexone in the treatment of alcohol dependence
30. Naltrexone and coping skills therapy for alcohol dependence
31. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: A controlled study
32. Hepatic, metabolic and toxic effects of ethanol: 1991 update
33. Fatty liver, hyperlipemia and hyperuricemia produced by prolonged alcohol consumption, despite adequate dietary intake
34. Fatty liver in the rat after prolonged intake of ethanol with a nutritionally adequate new liquid diet
35. An experimental model of alcohol feeding and liver injury in the baboon
36. Hepatic and other medical disorders of alcoholism: From pathogenesis to treatment
37. 6 metabolism in chronic alcohol abuse
38. Concentration of vitamin B6 and activities of enzymes of B6 metabolism in the blood of alcoholic and nonalcoholic men
39. The role of acetaldehyde in mediating the deleterious effect of ethanol on pyridoxal 5′-phosphate metabolism
40. Vitamin B6 metabolism in chronic alcohol abuse. The effect of ethanol oxidation on hepatic pyridoxal 5′-phosphate metabolism
41. Effect of acute alcohol ingestion on plasma pyridoxal 5′-phosphate
42. Clearance and metabolisms of plasma pyridoxial 5′ phosphate in the dog
43. Rate of disappearance from plasma of intravenously administered methionine in patients with liver damage
44. Evidence for impairment of transsulfuration pathway in cirrhosis
45. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis
46. Alcoholic liver disease: New insights in pathogenesis lead to new treatments
47. Methionine adenosyltransferase and liver disease: It's all about SAM
48. Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes
49. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon
50. Phospholipid methylation and biological signal transmission
51. Identification and properties of two methyltransferases in conversion of phosphatidylethanolamine to phosphatidylcholine
52. Chronic ethanol consumption alters rat liver plasma membranes and potentiates release of alkaline phosphatase
53. Intestinal absorption of S-adenosyl-L-methionine
54. Intestinal absorption of S-adenosyl-L-methionine in humans
55. S-adenosylmethionine and S-adenosylhomocysteine metabolism in isolated rat liver
56. Effect of exogenous S-adenosyl-L-methionine on phosphatidylcholine synthesis by isolated rat hepatocytes
57. Uptake and metabolism of S-adenosyl-L-methionine by isolated rat hepatocytes
58. Rates of oxidation of the methionine and S-adenosylmethionine methyl carbons in isolated rat hepatocytes
59. The use of ademethionine (SAMe) in the treatment of cholestatic liver disorders: Meta-analysis of clinical trials
60. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration
61. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis: A double-blind placebo controlled study
62. Effect of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease
63. S-Adenosylmethionine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicentre clinical trial
64. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon
65. Choline fails to prevent liver fibrosis in ethanol-fed baboons but causes toxicity
66. Choline and human nutrition
67. Tierexperimentelle studien zur pharmakokinetik der 'essentiellen' phospholipide (EPL)
68. Increased type I procollagen mRNA levels and in vitro protein synthesis in the baboon model of chronic alcoholic liver disease
69. Dilinoleoylphosphatidylcholine decreases hepatic stellate cell activation
70. Biochemical and morphological alterations of baboon hepatic mitochondria after chronic ethanol consumption
71. 3 content and changes in phospholipids
72. Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats
73. Ethanol and signal transduction in the liver
74. Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon
75. Polyenylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates its regression
76. Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured stellate cells
77. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: A multi-center, randomized, double blind, placebo-controlled trial
78. Alcohol, vitamin A, and beta-carotene: Adverse interactions, including hepatotoxicity and carcinogenicity
79. Interaction of ethanol with vitamin A
80. Hepatic vitamin A depletion in alcoholic liver injury
81. Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats
82. Changes in vitamin A status after acute ethanol administration in the rat
83. Increased metabolism of retinoic acid after chronic ethanol consumption in rat liver microsomes
84. Decreased hepatic vitamin A after drug administration in men and in rats
85. Hepatic vitamin A status of rats during feeding of hepatocarcinogen 2-aminoanthrequinone
86. Potentiation of ethanol-induced hepatic vitamin A depletion by phenobarbital and butylated hydroxytoluene
87. Metabolism of all-trans-retinoic acid in hamster liver microsomes: Oxidation of 4-hydroxy- to 4-keto retinoic acid
88. Retinoic acid metabolism by a system reconstituted with cytochrome P-450
89. New pathway for retinol metabolism in liver microsomes
90. Characteristic properties of a retinoic acid synthetic cytochrome P-450 purified from liver microsomes of 3-methylcholanthrene-induced rats
91. NAD+-dependent retinol dehydrogenase in liver microsomes
92. Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8
93. Effect of hepatic vitamin A depletion on the liver in humans and rats
94. Exacerbation by ethanol of liver injury due to vitamin A deficiency and excess
95. The effect of retinol on Ito cell proliferation in vitro
96. Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor β production
97. Retinol release by activated rat hepatic lipocytes: Regulation by Kupffer cell-conditioned medium and PDGF
98. Prevention of epithelial cancer by vitamin A and its synthetic analogs
99. Serum vitamin A (retinol) and cancer incidence in Evans County, Georgia
100. Potentiation by ethanol consumption of tracheal squamous metaplasia caused by vitamin A deficiency in rats
101. Interaction of drugs and retinol
102. Chronic alcohol intake reduces retinoic acid concentration and enhances AP-1 (c-Jun and c-Fos) Expression in rat liver
103. Alcohol dehydrogenase as a critical mediator of retinoic acid synthesis from vitamin A in the mouse embryo
104. Regional restriction of alcohol/retinol dehydrogenases along the mouse gastrointestinal epithelium
105. Hepatic injury from chronic hypervitaminosis A resulting in portal hypertension and ascites
106. Abnormal liver function in chronic hypervitaminosis A
107. Liver damage caused by therapeutic vitamin A administration: Estimate of dose related toxicity in 41 cases
108. Hepatotoxicity of vitamin A and ethanol in the rat
109. Treatment with vitamin A of sexual dysfunction in male alcoholics
110. Vitamin A hepatoxicity in multiple family members
111. Hypervitaminosis A: A liver lover's lament
112. Interactions between alcohol and beta-carotene in patients with alcoholic liver disease
113. The antioxidant status of patients with either alcohol-induced liver damage or myopathy
114. Effect of alcohol consumption on plasma carotenoid concentrations in premenopausal women: A controlled dietary study
115. Interaction of ethanol with β-carotene: Delayed blood clearance and enhanced hepatotoxicity
116. β-carotene beadlets potentiate hepatotoxicity of alcohol
117. The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers
118. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
119. Beta carotene, vitamin E, and lung cancer
120. Alcohol abuse: Carcinogenic effects and fetal alcohol syndrome
121. Co-carcinogenic effect of β-carotene
122. Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat
123. β-carotene: An unusual type of lipid antioxidant
124. Lycopene and β-carotene protect against oxidative damage in HT29 cells at low concentrations but rapidly lose this capacity at higher doses
125. β-carotene enhances hydrogen peroxide-induced DNA damage in human hepatocellular Hep G2 cells
126. α-tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of base-line characteristics and study compliance
127. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial
128. Effects of supplemental β-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the alpha tocopherol, beta-carotene cancer prevention study
129. Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats
130. On the role of alcohol dehydrogenase in ω-oxidation of fatty acids
131. Evidence for increased urate production by activation of adenine nucleotide turnover
132. The effect of ethanol on fatty acid metabolism: Stimulation of hepatic fatty acid synthesis in vitro
133. Cytochrome P4502E1: Its physiological and pathological role
134. Microsomal ethanol-oxidizing system (MEOS), the first 30 years (1968-1998) - A review
135. On the significance of the hypertrophy of the smooth endoplasmic reticulum in liver cells after administration of drugs
136. Pharmacological implications of microsomal enzyme induction
137. Effects of butylated hydroxytoluene on the ultrastructure of rat hepatocytes
138. Ethanol oxidation by hepatic microsomes: Adaptive increase after ethanol feeding
139. Hepatic microsomal ethanol oxidizing system: In vitro characteristics and adaptive properties in vivo
140. Reconstitution of the microsomal ethanol-oxidizing system: Qualitative and quantitative changes of cytochrome P-450 after chronic ethanol consumption
141. The direct oxidation of ethanol by catalase- and alcohol dehydrogenase-free reconstituted system containing cytochrome P-450
142. Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits
143. Purification and characterization of human liver cytochrome P-450-ALC
144. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver
145. Induction of P450E1 in human liver by ethanol is due to a corresponding increase in encoding mRNA
146. Respective roles of human cytochrome P4502E1, 1A2, and 3A4 in the hepatic microsomal ethanol oxidizing system
147. Non-uniformity of blood ethanol elimination: Its exaggeration after chronic consumption
148. Increased rate of tolbutamide metabolism in alcoholic patients
149. Increased rate of clearance of drugs from the circulation of alcoholics
150. Increase of ethanol meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats
151. Propranolol and sotaiol metabolism after a drinking party
152. Differences in the duration of the enhancement of liver mixed-function oxidase activities in ethanol-fed rats after withdrawal
153. Genetic environmental factors affecting ethanol metabolism in man
154. Alcohol-drugs interaction in man: Alcohol and tolbutamide
155. Effects of ethanol and phenobarbital on the metabolism of propanolol by 9000 g rat liver supernatant
156. Human and animal study on elimination from plasma and metabolism of diazepam after chronic alcohol intake
157. Ethanol-antibiotic interactions at hepatic level
158. Formation of 19(S)-, 19(R)-, and 18(R)-Hyroxyeicosatetraenoic acids by alcohol-inducible cytochrome P4502E1
159. Evidence that cytochrome P4502E1 is involved in the (ω-1)-hydroxylation of lauric acid in rat liver microsomes
160. Involvement of cytochrome P4502E1 in the (omega- 1)-hydroxylation of oleic acid in human and rat liver microsomes
161. Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes
162. Ummunochemical evidence for induction of the alcohol oxidizing cytochrome P450 isozyme 3a (P-450IIE1) as a benzene and phenol hydroxylase
163. Cytochrome P450IIE1: Roles in nitrosamine metabolism and mechanisms of regulation
164. Induction of P450IIE1 in the obese rat
165. Hepatic cytochrome P4502E1 is increased in patients with nonalcoholic steatohepatitis
166. Interaction of ethanol with enflurane metabolism and toxicity: Role of P450IIE1
167. Increased hepatotoxicity of acetaminophen after chronic ethanol consumption in the rat
168. Association of acetaminophen hepatotoxicity with fasting and ethanol use
169. Differential depletion of carotenoids and tocopherol in liver diseases
170. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism
171. Reduced nicotinamide-adenine dinucleotide phosphate oxidase: Activity enhanced by ethanol consumption
172. Stable expression of human cytochrome P4502E1 in HepG2 cells: Characterization of catalytic activities and production of reactive oxygen intermediates
173. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1)
174. Role of cytochrome P-4502E1 in ethanol-, carbon tetrachloride- and iron-dependent microsomal lipid peroxidation
175. Free radical metabolism of alcohols in rat liver microsomes
176. Reactive free radical generation in vivo in heart and liver of ethanol-fed rats: Correlation with radical formation in vitro
177. Spin trapping studies of hepatic free radicals formed following the acute administration of ethanol to rats: In vivo detection of 1- hydroxyethyl radicals with PBN
178. Induction of cytochrome P-4502E1 by ethanol in rat Kupffer cells
179. Role of alcohol dehydrogenase activity and of acetaldehyde in ethanol-induced ethane and pentane production by isolated perfused rat liver
180. Inhibition of ethanol- and aldehyde-induced release of ethane from isolated perfused rat liver by Pargyline and Disulfiram
181. Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease: Evidence of lipid peroxidation
182. Effects of chronic ethanol feeding on glutathione turnover in the rat
183. Increased loss of decreased synthesis of hepatic glutathione after acute ethanol administration
184. Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats
185. Chlormethiazole inhibition of cytochrome P4502E1 as assessed by chlorzoxazone hydroxylation in humans
186. Zonated expression of cytokines in rat liver: Effect of chronic ethanol and the cytochrome P4502E1 inhibitor, chlormethiazole
187. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers
188. Lipid peroxidation, CYP2E1 and arachidonic acid metabolism in alcoholic liver disease in rats
189. Inhibition of cytochrome P4502E1 expression by 2- (allylthio) pyrazine, a potential chemoprotective agent: Hepatoprotective effects
190. Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis
191. Modulation of experimental alcohol-induced liver disease by cytochrome P4502E1 inhibitors
192. Selective inhibition of cytochrome P4502E1 in vivo and in vitro with trans-1,2-dichloroethylene
193. Polyenylphosphatidylcholine opposes the increase of cytochrome P4502E1 by ethanol and corrects its iron-induced decrease
194. Effect of ethanol on cholesterol and bile acid metabolism
195. Depression of biliary glutathione excretion by chronic ethanol feeding in the rat
196. Ethanol-induced changes of intracellular thiol compartmentation and protein redox status in the rat liver: Effect of tauroursodeoxycholate
197. Ursodeoxychoic acid in the treatment of alcoholic liver disease
198. Taurine: Protective properties against ethanol-induced hepatic steatosis and lipid peroxidation during chronic ethanol consumption in rats
199. Ursodeoxycholate protects against ethanol-induced liver mitochondrial injury
200. Ursodeoxycholate alleviates alcoholic fatty liver damage in rats
201. Effects of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human hep G2 cell line
202. Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease
203. Effect of chronic alcohol feeding on hepatic iron status and ferritin uptake by rat hepatocytes
204. Hepatic and biliary levels of glutathione and lipid peroxides following iron overload in the rat: Effect of simultaneous ethanol administration
205. Effects of ethanol on fatty acid metabolism in liver slices
206. Role of dietary, adipose and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver
207. Effects of prolonged ethanol intake in man: Role of dietary, adipose, and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver
208. Quantitative relationship between the amount of dietary fat and the severity of the alcoholic fatty liver
209. Study of agents for the prevention of the fatty liver produced by prolonged alcohol intake
210. Difference in hepatic metabolism of long and medium-chain fatty acids: The role of fatty acid chain length in the production of the alcoholic fatty liver
211. Medium Chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease
212. Corticosteroid therapy of alcoholic hepatis
213. Methylprednisolone therapy in patients with severe alcoholic hepatitis: A randomized multicenter trial
214. The effect of prednisolone on the increased blood ammonia level in Eck fistula dogs
215. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials
216. A randomized trial of prednisolone in patients with severe alcoholic hepatitis
217. Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial
218. Intestinal endotoxins as mediators of hepatic injury-an idea whose time has come again
219. Intestinal endotoxins as co-factors in liver injury
220. Antibiotics prevent liver injury in rats following long term exposure to ethanol
221. Biologically active products of stimulated liver macrophages (Kupffer Cells)
222. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: Implication for a pathogenetic role in alcoholic liver fibrogenesis
223. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease
224. The role of Kupffer cells and reactive oxygen species in hepatic injury during acute and chronic alcohol intoxication
225. Decreased tumor necrosis factor- and interleukin-1 production from intrahepatic mononuclear cells in chronic ethanol consumption and up regulation by endotoxin
226. Molecular mechanism of induced hepatic macrophage cytokine gene expression in experimental alcoholic liver injury
227. Dilinoleoylphosphatidylcholine selectively modulates lipopolysaccharide-induced Kupffer cell activation
228. Dilinoleoylphosphatidylcholine (DLPC) decreases TNF-generation in acetaldehyde (ACH)-or lipopolysaccharide (LPS)-activated Kupffer cells of ethanol-fed rats
229. First international symposium on the molecular pathology and clinical aspects of the inflamed liver: Alcohol and cytokines
230. Cytokines in alcoholic liver disease
231. Immunologic reactions in alcoholic liver disease
232. Pericentral hepatic fibrosis and intracellular hyaline in diabetes mellitus
233. Hepatic collagen metabolism: Effect of alcohol consumption in rats and baboons
234. Alcohol as a stimulus to hepatic fibrogenesis
235. Hepatic collagen proline hydroxylase activity in alcoholic hepatitis: Effect of d-penicillamine
236. Collagen synthesis by liver stellate cells is released from its normal feedback regulation by acetaldehyde-induced modification of the carboxyl-terminal propeptide of procollagen
237. Dilinoleoylphosphatidylcholine decreases hepatic stellate cell activation
238. Regulation of collagen synthesis by ascorbic acid: Characterization of the role of ascorbate stimulated lipid peroxidation
239. Oxidative stress, antioxidants, and alcoholic liver fibrogenesis
240. Colchicine in the treatment of cirrhosis of the liver
241. Is colchicine effective therapy for cirrhosis?
242. Alcoholism is associated with hepatitis C but not hepatitis B in an urban population
243. Consensus conference: Liver transplantation
244. Liver transplantation in patients with alcoholic cirrhosis: Selection criteria and rates of survival and relapse
245. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease
246. Selection for and outcome of liver transplantation in alcoholic liver disease
247. Liver transplantation for alcoholic liver disease: Survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone